Trademark search for:

FAXVERZA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2023-07-12 — Application filed
2023-07-15 — Application filed
2023-08-11 — Application filed
2023-11-13 — Assigned to examiner
2023-11-15 — Final disposition recorded
2023-11-15 — Final disposition recorded
2023-11-15 — Final disposition recorded
2024-03-01 — Application abandoned
2024-03-01 — Application abandoned
2024-03-01 — Final status recorded
2024-06-04 — Teas withdrawal of attorney received-firm retains
2024-06-04 — Teas revoke/app/change addr of atty/dom rep received
2024-06-04 — Attorney/dom.rep.revoked and/or appointed
2024-06-04 — Teas change of correspondence received

Owner Information

Horizon Therapeutics Ireland DAC
Dublin 2 IE

Correspondent

Elsa D. Lemoine Amgen Inc.
One Amgen Center Drive
Trademark Operations - MS-28-5A
Thousand Oaks, CA 91320-1799

Filing Details

Filing Date:
2023-07-12

Status Date:
2024-03-01

Category:
Pharmaceuticals

Filing Year:
2023

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.